Last reviewed · How we verify

NCT05324553

Patient Derived Preclinical Models

Recruiting now Last updated 2 May 2025
What this trial tests

trial testing Tissue Collection in Cancer in 50 participants. Currently enrolling.

Timeline
6 April 2022
Primary endpoint
31 March 2027
31 March 2028

Quick facts

Lead sponsorMayo Clinic
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date6 April 2022
Primary completion31 March 2027
Estimated completion31 March 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study goal is to collect tumor specimens that may inform cancer biology to eventually improve outcomes for patients with cancer. This proposal represents a highly collaborative effort to support cancer research with the goal of developing novel therapeutic strategies using patient derived preclinical models. This study is being done to collect samples of tumor tissues, matched normal tissue when possible, and approximately 50 mL of blood.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Tumor microbiome - an integral part of the tumor microenvironment.
    Ciernikova S, Sevcikova A, Stevurkova V, Mego M. · · 2022 · cited 56× · PMID 36505811 · DOI 10.3389/fonc.2022.1063100

Verify or expand the search:

Other trials of Tissue Collection

Trials testing the same drug.

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05324553.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing